A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
- PMID: 30942690
- PMCID: PMC6447361
- DOI: 10.7554/eLife.45393
A type III-A CRISPR-Cas system employs degradosome nucleases to ensure robust immunity
Abstract
CRISPR-Cas systems provide sequence-specific immunity against phages and mobile genetic elements using CRISPR-associated nucleases guided by short CRISPR RNAs (crRNAs). Type III systems exhibit a robust immune response that can lead to the extinction of a phage population, a feat coordinated by a multi-subunit effector complex that destroys invading DNA and RNA. Here, we demonstrate that a model type III system in Staphylococcus epidermidis relies upon the activities of two degradosome-associated nucleases, PNPase and RNase J2, to mount a successful defense. Genetic, molecular, and biochemical analyses reveal that PNPase promotes crRNA maturation, and both nucleases are required for efficient clearance of phage-derived nucleic acids. Furthermore, functional assays show that RNase J2 is essential for immunity against diverse mobile genetic elements originating from plasmid and phage. Altogether, our observations reveal the evolution of a critical collaboration between two nucleic acid degrading machines which ensures cell survival when faced with phage attack.
Keywords: CRISPR-Cas10; Staphylococcus epidermidis; bacteriophage; degradosome; infectious disease; microbiology; type III CRISPR; virus.
© 2019, Chou-Zheng and Hatoum-Aslan.
Conflict of interest statement
LC, AH No competing interests declared
Figures
Similar articles
-
Critical roles for 'housekeeping' nucleases in type III CRISPR-Cas immunity.Elife. 2022 Dec 8;11:e81897. doi: 10.7554/eLife.81897. Elife. 2022. PMID: 36479971 Free PMC article.
-
Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases.Nucleic Acids Res. 2017 Feb 28;45(4):2112-2123. doi: 10.1093/nar/gkw891. Nucleic Acids Res. 2017. PMID: 28204542 Free PMC article.
-
Approaches to study CRISPR RNA biogenesis and the key players involved.Methods. 2020 Feb 1;172:12-26. doi: 10.1016/j.ymeth.2019.07.015. Epub 2019 Jul 17. Methods. 2020. PMID: 31325492 Review.
-
Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity.Cell. 2016 Feb 11;164(4):710-21. doi: 10.1016/j.cell.2015.12.053. Epub 2016 Feb 4. Cell. 2016. PMID: 26853474 Free PMC article.
-
The Escherichia coli RNA degradosome: structure, function and relationship in other ribonucleolytic multienzyme complexes.Biochem Soc Trans. 2002 Apr;30(2):150-5. Biochem Soc Trans. 2002. PMID: 12035760 Review.
Cited by
-
Bacterial RNA Degradosomes: Molecular Machines under Tight Control.Trends Biochem Sci. 2020 Jan;45(1):42-57. doi: 10.1016/j.tibs.2019.10.002. Epub 2019 Nov 1. Trends Biochem Sci. 2020. PMID: 31679841 Free PMC article. Review.
-
Controlling and enhancing CRISPR systems.Nat Chem Biol. 2021 Jan;17(1):10-19. doi: 10.1038/s41589-020-00700-7. Epub 2020 Dec 16. Nat Chem Biol. 2021. PMID: 33328654 Free PMC article. Review.
-
The structure of a Type III-A CRISPR-Cas effector complex reveals conserved and idiosyncratic contacts to target RNA and crRNA among Type III-A systems.PLoS One. 2023 Jun 23;18(6):e0287461. doi: 10.1371/journal.pone.0287461. eCollection 2023. PLoS One. 2023. PMID: 37352230 Free PMC article.
-
Genetic Engineering of Therapeutic Phages Using Type III CRISPR-Cas Systems.Methods Mol Biol. 2024;2734:279-299. doi: 10.1007/978-1-0716-3523-0_18. Methods Mol Biol. 2024. PMID: 38066376
-
Harnessing CRISPR-Cas system diversity for gene editing technologies.J Biomed Res. 2021 Mar 26;35(2):91-106. doi: 10.7555/JBR.35.20200184. J Biomed Res. 2021. PMID: 33797415 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
